R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Digital-health-is-not-about-big-data–it-is-about-people

Unlocking the potential of healthcare data in research

Health data research in the UK is rapidly evolving, with new capabilities emerging through the rise of hybrid engagement and the accelerated adoption of digital technologies.

R&D

Recent advances in neurological disorders

Considerable scientific progress across neurological diseases and disorders was reported at the recent 74th American Academy of Neurology (AAN) Annual Meeting.

R&D

The antimicrobial pipeline is ‘dry’ and that’s a problem

Antimicrobial resistance is a growing problem and one that is already claiming over a million lives per year.

Market Access

Saving lives doesn’t have to cost the Earth

Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), talks about how the healthcare industry needs to come t

Digital

How patient-on-a-chip tech could be the future of drug disco...

Testing drug compounds on a chip designed to mimic human organs sounds closer to science fiction than reality, yet the technology already exists and is already being put to use.

R&D